Lirui Yang

Lirui Yang

Auto-generated profile, based on publicly available information

Lirui Yang

Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2019 in Arthritis Research & Therapy
Verified
Journal Article
Open access
PDF file
LFLuyun Fan
Luyun Fan
HZHuimin Zhang
Huimin Zhang
JCJun Cai
Jun Cai
LYLirui Yang
Lirui Yang
BLBin Liu
Bin Liu
YLYing Lou
Ying Lou
Childhood Takayasu’s arteritis (c-TA) is scarcely reported but is characterized by devastating morbidity and mortality. This study aims to investigate the clinical course of c-TA and prognostic factors associated with rehospitalization and events including vascular complications, flares, and death. An ambispective study of 101 c-TA patients satisfying the American College of Rheumatology (ACR) criteria and/or the European League against Rheumatism (EULAR)/Pediatric Rheumatology International Trials Organization (PRINTO)/Pediatric Rheumatology European Society (PReS) criteria was conducted from January 2002 to December 2017. Data on demographic, clinical, laboratory, imaging, and therapeutic features were collected. Event-free survival, complication-free survival, flare-free survival, rehospitalization-free survival, and associated prognostic factors were assessed by Kaplan-Meier survival curve and propensity score analysis. The median age at c-TA onset was 14 (interquartile range (IQR) 12–16) years and 76.2% were female. Hypertension (70.3%), blood pressure discrepancy (55.4%), bruits (51.5%), and pulse deficits (37.6%) were core presentations. Major vascular involvement included the renal artery (62.4%), abdominal aorta (42.6%), subclavian artery (43.6%), and carotid artery (42.6%). Glucocorticoids (78.2%), antihypertensive drugs (72.3%), antiplatelet agents (72.3%), and revascularization (57.4%) were made up the majority administered. At a median 2.4 (IQR 0.7–6.1) years of follow-up, events, rehospitalization, vascular complications, flares and death were observed in 44.6%, 37.6%, 44.6%, 26.7%, and 3%, respectively. The 5-year event-free survival, rehospitalization-free survival, vascular complication-free survival, and flare-free survival were 42.8%, 55.8%, 45.9%, and 62.3%, respectively. Body mass index (BMI) (hazard ratio (HR) = 0.49, 95% confidence interval (CI) 0.30–0.81, p = 0.005), stroke (HR = 7.37, 95% CI 2.35–23.1, p = 0.001), and revascularization (HR = 0.51, 95% CI 0.27–0.94, p = 0.032) were independent prognostic predictors of events. Predictors for rehospitalization include age at admission (HR = 0.81, 95% CI 0.69–0.94, p = 0.006), renal artery involvement (HR = 0.49, 95% CI 0.25–0.96, p = 0.037), and elevated C-reactive protein (CRP; HR = 2.50, 95% CI 1.24–5.00, p = 0.01). BMI level (p = 0.024) and renal artery involvement (p = 0.015) were also associated with vascular complications, while revascularization (p = 0.002) independently correlated with re-flares. This large ambispective study of c-TA revealed an early 3% mortality at the first year and around 50% morbidity within 5 years after diagnosis. Hypertension, renal artery involvement, and revascularization based on anti-inflammation, antihypertension, and antiplatelet medications dominated c-TA with indications for optimistic prognosis. Patients with initial lower BMI level, a younger age at admission, stroke, and elevated CRP have a high risk of poor outcomes, requiring close c-TA monitoring and more aggressive management. NCT03199183 , unique protocol ID: 2016-ZX43. June 26, 2017

1 January 2019 in Journal of Diseases and Medicinal Plants
Verified
Journal Article
Open access
PDF file
XFXue Fang
Xue Fang
JLJinlei Liu
Jinlei Liu
LYLirui Yang
Lirui Yang
Xiang-Guo LiXiang-Guo Li
Xiang-Guo Li
Background: The main antibacterial component of Pulsatilla chinensis is anemonin, which has strong antibacterial effect, so it is studied. The Pulsatilla chinensis is one of the diseases that are difficult to solve in the growth of ginseng, but chemical control not only causes harm to the environment, but also has residues on ginseng itself. Pulsatilla is a good medicinal plant. It will have a certain effect on the prevention and treatment of ginseng disease, and it can do no residue, no harm to ginseng. Objective: This experiment can provide effective data support for the prevention and treatment of Pulsatilla chinensis. Method: In this experiment, Pulsatilla Chinensis was used as experimental materials to extract plant by reflux, ultrasonic extraction methods, the content of anemonin in each single factor experiment was determined by HPLC. According to the content, the response surface analysis method was used to find the best extraction process, and the mycelium growth rate method was further used to determine the antifungal effect of Alternaria panax. Results: The EC50 value of P. Chinensis extract to A. panax was methanol extract < acetone extract < ethanol extract in order from small to large; The optimum extraction conditions of anemonin, the effective component of P. Chinensis methanol extract, were as follows: methanol volume fraction 87%, extraction time 2 h, solid-liquid ratio 20 (V: m), the optimum extraction amount was 3.760 μg·g-1.

1 April 2021 in Journal Of Hypertension
Verified
Journal Article
Open access
FLFan Luyun
Fan Luyun
YLYang Lirui
Yang Lirui
WDWei Dongmei
Wei Dongmei
MWMa Wenjun
Ma Wenjun
LYLou Ying
Lou Ying
CJCai Jun
Cai Jun
Objective: Evidence-based studies on endovascular approaches for childhood Takayasu arteritis(c-TA) are limited. This study presented the real-world scenario of largest cohort up-to-date for c-TA patients undergoing interventions and their post-interventional outcomes. Design and method: Patients with c-TA satisfying the 1990 ACR or 2010 EULAR/PRINTO/PReS criteria were recruited from January 2002 to December 2017. Data on clinical, laboratory, imaging features, treatment and post-interventional outcomes were collected. Statistical analysis was performed based on data distribution. Complication-free survival and Re-intervention-free survival were projected by Kaplan-Meier methods and compared by Log-rank tests. Associated factors for intervention (or stenting) and predictors for post-interventional complications (or re-interventions) were assessed via Logistic regression and COX regression models, respectively. Results: Among 101 patients enrolled, 69(68.3%) underwent 121 interventions (Angioplasty 95; Stenting 26) during a median 3.1 years of follow-up. Compared with the medical treatment group, the intervention group appeared with fewer male population(18.8% vs 39.3%, OR = 0.2, p = 0.017) and more type IV disease(47.8% vs. 17.9%, OR = 10.60, p = 0.002). Male sex also indicated the risk for re-intervention(HR = 4.72, p = 0.016). Retinopathy(OR = 4.8, p = 0.027), time of delay in diagnosis per year(OR = 1.76, p = 0.016) and descending thoracic aorta involvement(OR = 10.19, p = 0.003) associated with stent insertion. Hypertension secondary to renal artery(59.4%) or mid-aorta(14.5%) stenosis, heart failure(21.7%), claudication(21.7%) served as leading clinical hints for interventions. Anti-inflammatory and anti-platelet therapies covered 89.9% and 91.3% patients, respectively. The technical success rate was 96.7%. Over median 2.88 years since intervention, 36 lesions occurred complications in 28 patients and 22 lesions in 17 patients, majorly on renal artery or mid-aorta. The 5-year complication-free and re-intervention survivals were 50.7% and 65.8%, separately. Dual antiplatelet therapy(HR = 0.28, p = 0.011), concurrent surgery(HR = 14.84, p = 0.002), retinopathy secondary to hypertension(HR = 3.54, p = 0.004), and pulmonary artery hypertension(HR = 3.0, p = 0.024) were independent predictors for complications. Conclusions: Over two-thirds c-TA patients require interventions and the 5-year complication-free survival is 50.7%. Male sex, retinopathy, and pulmonary artery hypertension alert unfavorable outcomes. Dual anti-platelet therapy appears to protect c-TA patients from post-interventional complications. Endovascular approaches can be a choice for mid-aorta and/or renal artery lesions caused by c-TA.

1 January 2024 in Journal of Interventional Cardiology
Verified
Journal Article
Open access
LYLirui Yang
Lirui Yang
TZTao Zhang
Tao Zhang
GWGang Wang
Gang Wang
LRLeisheng Ru
Leisheng Ru
LZLin Zhao
Lin Zhao
Objective: To compare the efficiency and safety of primary and bailout antegrade dissection and re‐entry (ADR) during percutaneous coronary intervention (PCI) for chronic total occluded (CTO) lesions.Methods: Patients who underwent ADR procedures for CTO lesions were enrolled in this study and were divided into two groups (primary ADR and bailout ADR) based on the initiation of ADR during PCI. The success rate and major adverse cardiovascular and cerebrovascular events (MACCE) during hospitalization were assessed as the primary endpoints. Procedure time, fluoroscopy time, wire crossing time, radiation dose, and contrast volume were considered as secondary endpoints.Results: A total of 243 patients were enrolled in this study, with 127 patients receiving primary ADR and 116 receiving bailout ADR. No differences were found in baseline parameters between the two groups. The success rate was significantly higher in the primary ADR group compared to the bailout ADR group (89.0% versus 77.6%, respectively; p = 0.017). The incidence of in‐hospital MACCE was low in both groups, with no significant differences observed between them. Procedure time, radiation dose, and contrast volume were lower in the primary ADR group compared to the bailout ADR group. Cox regression analysis revealed that primary ADR and J‐CTO score ≥ 3 were independent predictors of technical success in CTO‐PCI.Conclusions: Both primary and bailout ADR are safe strategies for CTO‐PCI. Primary ADR significantly improves the success rate of PCI for CTO compared to bailout ADR, with shorter operation time, lower radiation dose, and reduced contrast volume.

16 March 2026 in Journal of Investigative Medicine
Verified
Journal Article
Closed access
GLGuihua Li
Guihua Li
LYLirui Yang
Lirui Yang
TFTingting Feng
Tingting Feng
TZTao Zhang
Tao Zhang
LZLihui Zhou
Lihui Zhou
LZLin Zhao
Lin Zhao
Coronary artery calcium scoring (CCS) is a valuable non-invasive method for assessing atherosclerosis and performing risk stratification in patients with suspected coronary artery disease (CAD). Monocyte subsets play distinct roles in chronic inflammation and cardiovascular disease, potentially serving as biomarkers for CCS risk assessment. The aim of this study was to analyze the distribution of monocyte subsets in patients with suspected CAD and determine the association of monocyte subsets with CCS. A cohort of 182 individuals with suspected CAD was enrolled. Participants were stratified into three groups based on their CCS scores: very low-risk (CCS = 0), low-risk (CCS = 1−99), and moderate–high risk (CCS ≥ 100). Monocyte subsets were categorized according to CD14 and CD16 expression levels into classical, intermediate (intMo), and non-classical monocytes. Absolute counts and frequency distribution of monocyte subsets (FDMS, percentage of CD45+/CD14+/CD16+ events) were analyzed across all participants. Patients in the moderate–high risk CCS group had significantly higher absolute circulating monocyte counts than those in the other two groups ( p < 0.05). Furthermore, the moderate–high risk CCS group had the highest absolute intMo count and FDMS (percentage of CD45+/CD14+/CD16+ events, p < 0.05). Both the absolute intMo count (Model 1: odds ratio [OR] = 1.024, 95% confidence interval [CI]: 1.009−1.040, p = 0.002) and FDMS (percentage of CD45+/CD14+/CD16+ events, Model 2: OR = 1.109, 95% CI = 1.039−1.183, p = 0.002) were identified as independent risk factors for moderate–high risk CCS. These data suggest that intMo may be a useful biomarker for CCS risk stratification.